We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...

Louis Navellier is a prominent American investor, author, and financial analyst, best known for his quantitative approach to ...

The Food and Drug Administration approved Amgen Inc ‘s AMGN Lumakras (sotorasib) in combination with Vectibix (panitumumab) ...

Friday announced that the U.S. Food and Drug Administration has approved its Lumakras plus Vectibix combination ...

President-elect Donald Trump is hoping to make Hollywood “stronger than ever before” by naming Sylvester Stallone, Mel Gibson ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

To gain a panoramic view of Amgen's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.

The Amgen stock price suffered a harsh reversal in the fourth quarter of 2024 as its weight loss drug failed to excite. After peaking at $341 in July, the stock plunged by over 25% to the current $260 ...

"I am excited to welcome Sri to Caribou at the beginning of this pivotal ... Earlier in his career, he worked at Onyx Pharmaceuticals, Inc. and Amgen Inc. in finance-related positions of increasing ...

Drawing on my intuition, observation, and immersion—in a scene like no other—I see these predictions capturing the cutting edge of the cultural momentum. The midnight countdown isn’t just a ...